Diana Colleen discusses her novel They Could Be Saviors, psychedelic therapy, and how healing trauma could reshape empathy, connection, and the use of power.
Features
- Rhonda DeSantis
- No Comments
Why isn’t one psilocybin dose right for everyone? Rhonda DeSantis explains how compound profiles, patient needs, and integration shape treatment.
- raRÉ (The Psychedelic Biologist)
- No Comments
A biologist and brain aneurysm survivor recounts open-brain surgery, recovery, and a deeply personal journey with psilocybin, trauma, and renewal.
- Scott B. Montgomery
- No Comments
Lee Conklin is one of psychedelic art's most underappreciated visionaries. Explore his groundbreaking Fillmore posters, the iconic Santana album cover, and the intricate masterpieces that cement his legacy as a true architect of psychedelic art.
- Jill Sitnick
- No Comments
John Gilchrist of Therapsil explains how psilocybin therapy is helping end-of-life patients ease anxiety, find meaning, and embrace acceptance.
- Lindsay Kent
- No Comments
In 1970, Playboy gathered William S. Burroughs, Ram Dass, Alan Watts, Harry Anslinger and others for a debate that foreshadowed today's drug policy discussions.
- Jill Sitnick
- No Comments
Christian Rasmussen explains what people get wrong about Amanita muscaria, its reported effects, and key safety considerations.
- Lindsay Kent
- No Comments
From engineered psychedelics to LSD history, AI, and Mark McCloud’s surreal world, Lindsay Kent explores consciousness, culture, and human connection.
- Jill Sitnick
- No Comments
In this episode of the Psychedelic Scene Podcast, Jill Sitnick sits down with Rhonda DeSantis, founder of Psylutions and one of Colorado’s first licensed psilocybin cultivators, manufacturers, and distributors.